Tech Company Financing Transactions

Avistone Pharmaceuticals Funding Round

Vivo Capital, Bain Capital Ventures and Primavera Capital participated in a $200 million capital raise for Avistone Pharmaceuticals. The round was announced by the company on 12/9/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Beijing, Undisclosed
China

Phone

Undisclosed

Website

Email Address

Not Recorded

Overview

Avistone is a clinical-stage biotechnology company based in Beijing, China, focusing on researching and developing innovative therapies for patients with significant unmet medical needs globally.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Hepeng Shi

        

Browse more venture capital transactions:

Prev: 12/9/2021: Quinio venture capital transaction
Next: 12/9/2021: Tipalti venture capital transaction

Share this article

News on VC Transactions

We report on tech company VC transactions. VC investment data records on this site are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary